Clinical News

New Phase I study shows up to 6,000mg of CBD relatively well tolerated in healthy participants

Published by External Author,
30, Oct

A new study has found that 6,000mg of CBD is relatively well tolerated in healthy participants.

Research into the impacts of CDB on the body

A phase I study released in October this year sought to asses the safety, tolerability and PK of CBD oral solution in healthy adult volunteers, as well as the effect of food on CBD PK parameters. The results showed encouraging signs that CDB was tolerated.


To read the full study click here

You might also be interested in

Insights

Everything you need to know about medical cannabis

Published by External Author.

22 Oct

Insights

Cannabis helping those with chronic pain

Published by External Author.

24 Oct

View all articles